HEADER LYASE 30-JAN-08 3C56 TITLE CLASS II FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE FROM HELICOBACTER PYLORI TITLE 2 IN COMPLEX WITH N-(3-HYDROXYPROPYL)-GLYCOLOHYDROXAMIC ACID TITLE 3 BISPHOSPHATE, A COMPETITIVE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: FRUCTOSE-BISPHOSPHATE ALDOLASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 4.1.2.13; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HELICOBACTER PYLORI; SOURCE 3 ORGANISM_TAXID: 210; SOURCE 4 GENE: FBA; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: JM109; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PKK233-3 KEYWDS CLASS II, FBP, ALDOLASE, GLYCOLYSIS, INHIBITOR, LYASE, METAL-BINDING, KEYWDS 2 ZINC EXPDTA X-RAY DIFFRACTION AUTHOR M.COINCON,J.SYGUSCH,P.POTVIN-DULUDE REVDAT 9 03-APR-24 3C56 1 REMARK REVDAT 8 21-FEB-24 3C56 1 REMARK SEQADV REVDAT 7 24-JUL-19 3C56 1 REMARK REVDAT 6 24-JAN-18 3C56 1 AUTHOR REVDAT 5 24-FEB-09 3C56 1 VERSN REVDAT 4 14-OCT-08 3C56 1 JRNL REVDAT 3 09-SEP-08 3C56 1 REMARK REVDAT 2 02-SEP-08 3C56 1 TITLE REVDAT 1 26-AUG-08 3C56 0 JRNL AUTH M.FONVIELLE,M.COINCON,R.DAHER,N.DESBENOIT,K.KOSIERADZKA, JRNL AUTH 2 N.BARILONE,B.GICQUEL,J.SYGUSCH,M.JACKSON,M.THERISOD JRNL TITL SYNTHESIS AND BIOCHEMICAL EVALUATION OF SELECTIVE INHIBITORS JRNL TITL 2 OF CLASS II FRUCTOSE BISPHOSPHATE ALDOLASES: TOWARDS NEW JRNL TITL 3 SYNTHETIC ANTIBIOTICS. JRNL REF CHEMISTRY V. 14 8521 2008 JRNL REFN ISSN 0947-6539 JRNL PMID 18688832 JRNL DOI 10.1002/CHEM.200800857 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 726.00 REMARK 3 COMPLETENESS FOR RANGE (%) : 82.6 REMARK 3 NUMBER OF REFLECTIONS : 21015 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.172 REMARK 3 FREE R VALUE : 0.208 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.700 REMARK 3 FREE R VALUE TEST SET COUNT : 1460 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 K_SOL : NULL REMARK 3 B_SOL : 44.81 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.84 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.10900 REMARK 3 B22 (A**2) : 1.18900 REMARK 3 B33 (A**2) : 0.92000 REMARK 3 B12 (A**2) : -0.69200 REMARK 3 B13 (A**2) : 1.65100 REMARK 3 B23 (A**2) : -10.36000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 NULL REMARK 3 ANGLE : 0.618 NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3C56 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-FEB-08. REMARK 100 THE DEPOSITION ID IS D_1000046354. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-AUG-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X29A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28829 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.990 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 0.7 REMARK 200 DATA REDUNDANCY : 1.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07000 REMARK 200 FOR THE DATA SET : 8.7500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.99 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.06 REMARK 200 COMPLETENESS FOR SHELL (%) : 28.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHENIX AUTOMR REMARK 200 STARTING MODEL: FREE ENZYME STRUCTURE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.87 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.19 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12% PEG 1000, 12% PEG 8000, 0.2 M REMARK 280 CALCIUM ACETATE,50 MM TRIS/HOAC, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 297K, PH 8 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3800 ANGSTROM**2 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 142 REMARK 465 ASP A 143 REMARK 465 ASN A 144 REMARK 465 ILE A 145 REMARK 465 SER A 146 REMARK 465 VAL A 147 REMARK 465 ASP A 148 REMARK 465 GLU A 149 REMARK 465 LYS A 150 REMARK 465 ASP A 151 REMARK 465 GLY B 140 REMARK 465 ILE B 141 REMARK 465 GLU B 142 REMARK 465 ASP B 143 REMARK 465 ASN B 144 REMARK 465 ILE B 145 REMARK 465 SER B 146 REMARK 465 VAL B 147 REMARK 465 ASP B 148 REMARK 465 GLU B 149 REMARK 465 LYS B 150 REMARK 465 ASP B 151 REMARK 465 ALA B 152 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL B 153 CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 26 -170.00 -160.81 REMARK 500 PHE A 183 78.68 -115.02 REMARK 500 ASP A 255 -54.36 -146.21 REMARK 500 LYS B 186 44.92 -85.16 REMARK 500 ASP B 255 -56.32 -141.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 308 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 83 NE2 REMARK 620 2 HIS A 180 NE2 105.1 REMARK 620 3 HIS A 210 ND1 84.9 111.8 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 308 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 83 NE2 REMARK 620 2 HIS B 180 NE2 109.5 REMARK 620 3 HIS B 210 ND1 82.1 119.4 REMARK 620 N 1 2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 308 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 308 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PH4 A 309 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PH4 B 309 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3C4U RELATED DB: PDB REMARK 900 SAME PROTEIN WITHOUT ANY INHIBITOR LIGAND. REMARK 900 RELATED ID: 3C52 RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH PGH INHIBITOR LIGAND. DBREF 3C56 A 1 307 UNP P56109 ALF_HELPY 1 307 DBREF 3C56 B 1 307 UNP P56109 ALF_HELPY 1 307 SEQADV 3C56 ALA A 48 UNP P56109 THR 48 CONFLICT SEQADV 3C56 ILE A 67 UNP P56109 THR 67 CONFLICT SEQADV 3C56 ALA B 48 UNP P56109 THR 48 CONFLICT SEQADV 3C56 ILE B 67 UNP P56109 THR 67 CONFLICT SEQRES 1 A 307 MET LEU VAL LYS GLY ASN GLU ILE LEU LEU LYS ALA HIS SEQRES 2 A 307 LYS GLU GLY TYR GLY VAL GLY ALA PHE ASN PHE VAL ASN SEQRES 3 A 307 PHE GLU MET LEU ASN ALA ILE PHE GLU ALA GLY ASN GLU SEQRES 4 A 307 GLU ASN SER PRO LEU PHE ILE GLN ALA SER GLU GLY ALA SEQRES 5 A 307 ILE LYS TYR MET GLY ILE ASP MET ALA VAL GLY MET VAL SEQRES 6 A 307 LYS ILE MET CYS GLU ARG TYR PRO HIS ILE PRO VAL ALA SEQRES 7 A 307 LEU HIS LEU ASP HIS GLY THR THR PHE GLU SER CYS GLU SEQRES 8 A 307 LYS ALA VAL LYS ALA GLY PHE THR SER VAL MET ILE ASP SEQRES 9 A 307 ALA SER HIS HIS ALA PHE GLU GLU ASN LEU GLU LEU THR SEQRES 10 A 307 SER LYS VAL VAL LYS MET ALA HIS ASN ALA GLY VAL SER SEQRES 11 A 307 VAL GLU ALA GLU LEU GLY ARG LEU MET GLY ILE GLU ASP SEQRES 12 A 307 ASN ILE SER VAL ASP GLU LYS ASP ALA VAL LEU VAL ASN SEQRES 13 A 307 PRO LYS GLU ALA GLU GLN PHE VAL LYS GLU SER GLN VAL SEQRES 14 A 307 ASP TYR LEU ALA PRO ALA ILE GLY THR SER HIS GLY ALA SEQRES 15 A 307 PHE LYS PHE LYS GLY GLU PRO LYS LEU ASP PHE GLU ARG SEQRES 16 A 307 LEU GLN GLU VAL LYS ARG LEU THR ASN ILE PRO LEU VAL SEQRES 17 A 307 LEU HIS GLY ALA SER ALA ILE PRO ASP ASN VAL ARG LYS SEQRES 18 A 307 SER TYR LEU ASP ALA GLY GLY ASP LEU LYS GLY SER LYS SEQRES 19 A 307 GLY VAL PRO PHE GLU PHE LEU GLN GLU SER VAL LYS GLY SEQRES 20 A 307 GLY ILE ASN LYS VAL ASN THR ASP THR ASP LEU ARG ILE SEQRES 21 A 307 ALA PHE ILE ALA GLU VAL ARG LYS VAL ALA ASN GLU ASP SEQRES 22 A 307 LYS SER GLN PHE ASP LEU ARG LYS PHE PHE SER PRO ALA SEQRES 23 A 307 GLN LEU ALA LEU LYS ASN VAL VAL LYS GLU ARG MET LYS SEQRES 24 A 307 LEU LEU GLY SER ALA ASN LYS ILE SEQRES 1 B 307 MET LEU VAL LYS GLY ASN GLU ILE LEU LEU LYS ALA HIS SEQRES 2 B 307 LYS GLU GLY TYR GLY VAL GLY ALA PHE ASN PHE VAL ASN SEQRES 3 B 307 PHE GLU MET LEU ASN ALA ILE PHE GLU ALA GLY ASN GLU SEQRES 4 B 307 GLU ASN SER PRO LEU PHE ILE GLN ALA SER GLU GLY ALA SEQRES 5 B 307 ILE LYS TYR MET GLY ILE ASP MET ALA VAL GLY MET VAL SEQRES 6 B 307 LYS ILE MET CYS GLU ARG TYR PRO HIS ILE PRO VAL ALA SEQRES 7 B 307 LEU HIS LEU ASP HIS GLY THR THR PHE GLU SER CYS GLU SEQRES 8 B 307 LYS ALA VAL LYS ALA GLY PHE THR SER VAL MET ILE ASP SEQRES 9 B 307 ALA SER HIS HIS ALA PHE GLU GLU ASN LEU GLU LEU THR SEQRES 10 B 307 SER LYS VAL VAL LYS MET ALA HIS ASN ALA GLY VAL SER SEQRES 11 B 307 VAL GLU ALA GLU LEU GLY ARG LEU MET GLY ILE GLU ASP SEQRES 12 B 307 ASN ILE SER VAL ASP GLU LYS ASP ALA VAL LEU VAL ASN SEQRES 13 B 307 PRO LYS GLU ALA GLU GLN PHE VAL LYS GLU SER GLN VAL SEQRES 14 B 307 ASP TYR LEU ALA PRO ALA ILE GLY THR SER HIS GLY ALA SEQRES 15 B 307 PHE LYS PHE LYS GLY GLU PRO LYS LEU ASP PHE GLU ARG SEQRES 16 B 307 LEU GLN GLU VAL LYS ARG LEU THR ASN ILE PRO LEU VAL SEQRES 17 B 307 LEU HIS GLY ALA SER ALA ILE PRO ASP ASN VAL ARG LYS SEQRES 18 B 307 SER TYR LEU ASP ALA GLY GLY ASP LEU LYS GLY SER LYS SEQRES 19 B 307 GLY VAL PRO PHE GLU PHE LEU GLN GLU SER VAL LYS GLY SEQRES 20 B 307 GLY ILE ASN LYS VAL ASN THR ASP THR ASP LEU ARG ILE SEQRES 21 B 307 ALA PHE ILE ALA GLU VAL ARG LYS VAL ALA ASN GLU ASP SEQRES 22 B 307 LYS SER GLN PHE ASP LEU ARG LYS PHE PHE SER PRO ALA SEQRES 23 B 307 GLN LEU ALA LEU LYS ASN VAL VAL LYS GLU ARG MET LYS SEQRES 24 B 307 LEU LEU GLY SER ALA ASN LYS ILE HET ZN A 308 1 HET PH4 A 309 18 HET ZN B 308 1 HET PH4 B 309 18 HETNAM ZN ZINC ION HETNAM PH4 3-{HYDROXY[(PHOSPHONOOXY)ACETYL]AMINO}PROPYL DIHYDROGEN HETNAM 2 PH4 PHOSPHATE FORMUL 3 ZN 2(ZN 2+) FORMUL 4 PH4 2(C5 H13 N O10 P2) FORMUL 7 HOH *593(H2 O) HELIX 1 1 LYS A 4 GLY A 16 1 13 HELIX 2 2 ASN A 26 GLU A 40 1 15 HELIX 3 3 GLU A 50 GLY A 57 1 8 HELIX 4 4 GLY A 57 ARG A 71 1 15 HELIX 5 5 THR A 86 GLY A 97 1 12 HELIX 6 6 ALA A 109 ALA A 127 1 19 HELIX 7 7 ASN A 156 GLN A 168 1 13 HELIX 8 8 ASP A 192 ASN A 204 1 13 HELIX 9 9 PRO A 216 ALA A 226 1 11 HELIX 10 10 PRO A 237 GLY A 248 1 12 HELIX 11 11 ASP A 255 ASP A 273 1 19 HELIX 12 12 ASP A 278 GLY A 302 1 25 HELIX 13 13 LYS B 4 GLY B 16 1 13 HELIX 14 14 ASN B 26 GLU B 40 1 15 HELIX 15 15 GLU B 50 GLY B 57 1 8 HELIX 16 16 GLY B 57 TYR B 72 1 16 HELIX 17 17 THR B 86 GLY B 97 1 12 HELIX 18 18 ALA B 109 ALA B 127 1 19 HELIX 19 19 ASN B 156 GLN B 168 1 13 HELIX 20 20 ASP B 192 ASN B 204 1 13 HELIX 21 21 PRO B 216 ALA B 226 1 11 HELIX 22 22 PRO B 237 GLY B 248 1 12 HELIX 23 23 ASP B 255 ASP B 273 1 19 HELIX 24 24 ASP B 278 GLY B 302 1 25 SHEET 1 A 9 VAL A 19 ASN A 23 0 SHEET 2 A 9 LEU A 44 SER A 49 1 O PHE A 45 N PHE A 22 SHEET 3 A 9 VAL A 77 GLY A 84 1 O HIS A 80 N ILE A 46 SHEET 4 A 9 SER A 100 ILE A 103 1 O SER A 100 N LEU A 81 SHEET 5 A 9 SER A 130 LEU A 135 1 O GLU A 132 N ILE A 103 SHEET 6 A 9 TYR A 171 PRO A 174 1 O ALA A 173 N ALA A 133 SHEET 7 A 9 LEU A 207 LEU A 209 1 O VAL A 208 N LEU A 172 SHEET 8 A 9 ILE A 249 THR A 254 1 O LYS A 251 N LEU A 209 SHEET 9 A 9 VAL A 19 ASN A 23 1 N VAL A 19 O ASN A 250 SHEET 1 B 9 VAL B 19 ASN B 23 0 SHEET 2 B 9 LEU B 44 SER B 49 1 O GLN B 47 N PHE B 22 SHEET 3 B 9 VAL B 77 GLY B 84 1 O HIS B 80 N ILE B 46 SHEET 4 B 9 SER B 100 ILE B 103 1 O SER B 100 N LEU B 81 SHEET 5 B 9 SER B 130 LEU B 135 1 O GLU B 132 N ILE B 103 SHEET 6 B 9 TYR B 171 PRO B 174 1 O ALA B 173 N ALA B 133 SHEET 7 B 9 LEU B 207 LEU B 209 1 O VAL B 208 N LEU B 172 SHEET 8 B 9 ILE B 249 THR B 254 1 O LYS B 251 N LEU B 209 SHEET 9 B 9 VAL B 19 ASN B 23 1 N VAL B 19 O ASN B 250 LINK NE2 HIS A 83 ZN ZN A 308 1555 1555 2.19 LINK NE2 HIS A 180 ZN ZN A 308 1555 1555 2.24 LINK ND1 HIS A 210 ZN ZN A 308 1555 1555 2.17 LINK NE2 HIS B 83 ZN ZN B 308 1555 1555 2.18 LINK NE2 HIS B 180 ZN ZN B 308 1555 1555 2.16 LINK ND1 HIS B 210 ZN ZN B 308 1555 1555 2.23 SITE 1 AC1 3 HIS A 83 HIS A 180 HIS A 210 SITE 1 AC2 3 HIS B 83 HIS B 180 HIS B 210 SITE 1 AC3 15 ASN A 23 SER A 49 ASP A 82 HIS A 83 SITE 2 AC3 15 HIS A 180 GLY A 181 LYS A 184 GLY A 211 SITE 3 AC3 15 ALA A 212 SER A 213 ASN A 253 ASP A 255 SITE 4 AC3 15 THR A 256 ARG A 259 ARG B 280 SITE 1 AC4 17 ARG A 280 ASN B 23 SER B 49 ASP B 82 SITE 2 AC4 17 HIS B 83 HIS B 180 GLY B 181 LYS B 184 SITE 3 AC4 17 HIS B 210 GLY B 211 ALA B 212 SER B 213 SITE 4 AC4 17 ASN B 253 THR B 254 ASP B 255 THR B 256 SITE 5 AC4 17 ARG B 259 CRYST1 39.222 62.005 65.615 82.90 79.77 71.03 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025496 -0.008764 -0.003991 0.00000 SCALE2 0.000000 0.017054 -0.001210 0.00000 SCALE3 0.000000 0.000000 0.015526 0.00000